Talcum Powder Cancer Lawsuit

Key Talc Testing Expert Testified That Scientific Studies Used Inadequate Asbestos Testing Methods

Johnson & Johnson's claim that their talc is asbestos-free falls short due to poor detection methods

Monday, July 3, 2023 - Let us not forget that in December 2019, Dr. William Longo testified before the US House of Representatives Committee on Oversight and Reform regarding his work testing talc, the active ingredient in Johnson's Baby Powder, for the presence of asbestos, a deadly carcinogen. Dr. Longo holds a Ph.D. in the area of material science and engineering. He is the president of Materials Analytical Services, LLC (MAS), a laboratory specializing in materials analysis, including asbestos analysis. Dr. Longo has over 30 years of experience in asbestos analysis and research. Dr. Longo has testified as an expert witness in cases on behalf of both plaintiffs and defendants. His most recent work centers around the findings of asbestos in Johnson's Baby Powder during numerous talcum powder ovarian cancer trials. His expertise in the field of material science and engineering, particularly in asbestos analysis, lends credibility to his testimony on determining asbestos in cosmetic talc. During his testimony, Dr. Longo discussed the methods for determining asbestos in cosmetic talc, citing numerous independent labs, including AMA Analytical, Forensic Analytical, MVA Scientific Consultants, MAS, and even Johnson & Johnson's own consultants, which have documented the presence of asbestos in consumer talc products, such as Johnson's baby powder.

Dr. Longo states that the talc industry has accumulated many testing results reporting no detectable asbestos, but these reports are misleading due to poor detection limits resulting from inadequate testing methods. The main issue Dr. Longo addressed in his testimony was the failure of testing methods used by the cosmetic talc industry to detect asbestos. He asserts that the current methods lack the sensitivity required to detect trace levels of asbestos. Asbestos fibers are extremely small and lightweight, measured in picograms. Even if the asbestos content by weight is less than 0.01 percent, there can be millions of asbestos fibers in a single gram of talc. Thus, highly sensitive analytical methods with low detection limits are crucial. Dr. Longo criticizes the laboratories used by the talc industry, including an FDA contract laboratory, for their poor analytical sensitivity, with detection limits ranging from 10 million to 14 million asbestos fibers per gram. He explains that a single asbestos fiber must be visible to the analyst for detection, and any method must allow for the detection of asbestos in samples that are predominantly talc. The nations leading Talcum powder cancer lawyers continue to accept clients with ovarian cancer due to using Johnson’s Baby Powder.

Dr. Longo proposes the use of a sample preparation method called heavy liquid separation (HLS), which can separate talc particles and enhance the detection of amphibole asbestos. He states that his laboratory has achieved an analytical sensitivity of approximately 4,500 asbestos fibers per gram using HLS and transmission electron microscopy (TEM). According to their analysis, approximately 65 percent of cosmetic samples tested in the last three years contained amphibole asbestos. Notably, Mr. Longo points out that the HLS method is not new and was developed in the early 1970s by the Colorado School of Mines and Dartmouth University, who presented it to Johnson & Johnson. However, the company did not adopt the method, suggesting that it may have been deemed too sensitive and not in their best interest.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.